Bepotastine

DEA Class; Rx

Common Brand Names; Bepreve

  • Antihistamines, Ophthalmic

Ophthalmic antihistamine and mast cell stabilizer
For treatment of itching due to allergic conjunctivitis
Remove contact lenses before and for 10 minutes after the dose

Indicated for the treatment of itching (ocular pruritus) associated with signs and symptoms of allergic conjunctivitis.

Hypersensitivity

  • Mild taste disturbance (25%)
  • Ocular irritation (2-5%)
  • Headache (2-5%)
  • Nasopharyngitis (2-5%)

Remove contact lenses prior to instillation; benzalkonium chloride may be absorbed by soft contact lenses

To minimize contaminating dropper tip and solution, advise the patient not to touch the eyelids

Store at room temp; protect from light & excessive heat

Keep bottle tightly closed when not in use

Do not wear contact lenses if eye is red

There are no available human data for use during pregnancy to inform any drug-associated risks

There are no data on human milk, effects on breastfed infant or milk production; developmental and health benefits of breastfeeding should be considered, along with mother’s clinical need for therapy, and any potential adverse effects on breastfed infant

Adults

2 drops/day per eye.

Elderly

2 drops/day per eye.

Adolescents

2 drops/day per eye.

Children

>= 2 years: 2 drops/day per eye.
< 2 years: Safety and efficacy have not been established.

Infants

Safety and efficacy have not been established.

Neonates

Safety and efficacy have not been established.

Bepotastine besilate

ophthalmic solution

  • 1.5% (10mL)

About the Author

You may also like these

0